Table 3. Correlation between mutated plasma EGFR response and clinical response evaluated by RECIST criteria.
Plasma EGFR Response | Clinical Response | |||
---|---|---|---|---|
Progressive disease | Stable disease | Partial response | TOTAL | |
Poor responder | 5 (71.4%) | 2 (28.6%) | 0 (0%) | 7 (100%) |
Good responder | 3 (5.3%) | 15 (26.3%) | 39 (68.4%) | 57 (100%) |
TOTAL | 8 (12.5%) | 17 (26.6%) | 39 (60.9%) | 64 (100%) |